Abstract
Purposes
To determine the incidence, obstetrical, and fetal complication rates of intrahepatic cholestasis of pregnancy (ICP) in patients managed expectantly to 40-weeks gestation.
Methods
In a prospective cohort study conducted between February 2008 and January 2010, a total of 21,960 pregnant women in Qassim Region of Saudi Arabia were screened for ICP using specific criteria for diagnosis. The course of pregnancy was monitored to 40-weeks gestation or spontaneous onset of labor, whichever comes first. The measured outcomes were compared with a cross-matched group of healthy pregnant women. Continuous variables were analyzed with t test, while χ2 test was used for comparing percentages.
Results
The incidence of ICP was 0.35% (76/21,960). There was no significant difference between groups in gestational age at delivery, preterm labor, intrauterine fetal death, cesarean section, or respiratory distress syndrome. There was significantly higher intrapartum non-reassuring fetal heart rate patterns and meconium-stained amniotic fluid in ICP group (P < 0.01 and <0.0001, respectively).
Conclusions
The incidence of ICP in this region is low compared to worldwide range. Expectant management to 40-weeks gestation is associated with obstetrical and fetal outcomes comparable to normal pregnancy; however, intrapartum fetal asphyxia is more likely.
Similar content being viewed by others
References
Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR (2007) The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch Dermatol 143:757–762
Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM (2006) The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 54:395–404
Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World J Gastroenterol 15:2049–2066
Kroumpouzos G (2002) Intrahepatic cholestasis of pregnancy: what’s new. JEADV 16:316–318
Lee RH, Goodwin TM, Greenspoon J, Incerpi M (2006) The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26:527–532
Ruetz S, Gros P (1994) Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77:1071–1081
Smith AJ, Timmermans-Hereijgers JL, Roelofsen B, Wirtz KW, van Blitterswijk WJ, Smit JJ et al (1994) The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett 354:263–266
Yamamoto Y, Moore R, Hess HA, Guo GL, Gonzalez FJ, Korach KS et al (2006) Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J Biol Chem 281:16625–16631
Rathi U, Bapat M, Rathi P, Abraham P (2007) Effect of liver disease on maternal and fetal outcome: a prospective study. Indian J Gastroenterol 26:59–63
Kroumpouzos G, Cohen LM (2001) Dermatoses of pregnancy. J Am Acad Dermatol 45:1–19
Reyes H, Báez ME, González MC, Hernández I, Palma J, Ribalta J et al (2000) Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 32:542–549
Reyes H, Taboada G, Ribalta J (1979) Prevalence of intrahepatic cholestasis of pregnancy in La Paz, Bolivia. J Chronic Dis 32:499–504
Shaw D, Frohlich J, Wittmann BA, Willms MA (1982) Prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 142:621–625
Lo TK, Lau WL, Lam HS, Leung WC, Chin RK (2007) Obstetric cholestasis in Hong Kong—local experience with eight consecutive cases. Hong Kong Med J 13:387–391
Williamson C, Hems LM, Goulis DG, Walker I, Chambers J, Donaldson O et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111:676–681
Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F (1997) Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 26:358–364
Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 40:467–474
Laatikainen T, Ikonen E (1977) Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 50:313–318
Laatikainen T, Tulenheimo A (1984) Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22:91–94
Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, Incerpi M, Pathak B, Goodwin TM (2008) Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol 25:341–345
Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95:1137–1143
Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A (2002) Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 100:167–170
Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170:890–895
Reid R, Ivey KJ, Rencoret RH, Storey B (1976) Fetal complications of obstetric cholestasis. Br Med J 1:870–872
Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E (1995) Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 37:580–584
Morrison JJ, Rennie JM, Milton PJ (1995) Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 102:101–106
Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC (2001) Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 10:131–135
Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A (1996) Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 52:133–140
Royal College of Obstetricians and Gynaecologists (2001) The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. Evidence based clinical guideline 8
Nordstrom L, Marcus C, Persson B, Shimojod N, Westgren M (1996) Lactate in cord blood and its relationship to pH and catecholamines in spontaneous vaginal deliveries. Early Hum Dev 46:97–104
American College of Obstetricians and Gynecologists (2006) Postpartum hemorrhage. ACOG Practice Bulletin No. 76
Heinonen S, Kirkinen P (1999) Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 94:189–193
Kauppila A, Korpela H, Mäkilä UM, Yrjänheikki E (1987) Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. Br Med J (Clin Res Ed) 294:150–152
Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O (1981) Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 88:240–245
Porembka DT, Kier A, Sehlhorst S, Boyce S, Orlowski JP, Davis K Jr (1993) The pathophysiologic changes following bile aspiration in a porcine lung model. Chest 104:919–924
Sepúlveda WH, González C, Cruz MA, Rudolph MI (1991) Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol 42:211–215
Miller PW, Coen RW, Benirschke K (1985) Dating the time interval from meconium passage to birth. Obstet Gynecol 66:459–462
Campos GA, Guerra FA, Israel EJ (1986) Effects of cholic acid infusion in fetal lambs. Acta Obstet Gynecol Scand 65:23–26
Falconer JD, Smith AN, Eastwood MA (1980) The effects of bile acids on colonic motility in the rabbit. Q J Exp Physiol Cogn Med Sci 65:135–144
Williamson C, Gorelik J, Eaton BM, Lab M, de Swiet M, Korchev Y (2001) The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intrauterine fetal death in obstetric cholestasis. Clin Sci (Lond) 100:363–369
Conflict of interest statement
The authors have no a financial relationship with organizations that sponsored the research or any conflict of interest to be declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al Shobaili, H.A., Hamed, H.O., Al Robaee, A. et al. Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy. Arch Gynecol Obstet 283, 1219–1225 (2011). https://doi.org/10.1007/s00404-010-1506-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1506-1